SC 13D Filing

Company

Insight Molecular Diagnostics Inc.

Filed

September 8, 2016

Accession Number

0000919574-16-015304

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →